Key Capital Corporation Announces Groundbreaking Liver Cancer Immunotherapy Results – Yahoo Finance
|
Key Capital Corporation Announces Groundbreaking Liver Cancer Immunotherapy Results
Yahoo Finance This study has also shown that after a median 2 months of treatment 50 out of 75 patients had their hepatic tumor marker, alpha-fetoprotein or AFP, decline, which indicates that two thirds of the study population responded to immunotherapy, since the … |
